These authors contributed equally to the work and share first authorship.
International Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark.
Euro Surveill. 2024 Jun;29(24). doi: 10.2807/1560-7917.ES.2024.29.24.2300652.
BackgroundDenmark possesses an exceptional historical data collection on tuberculosis (TB) from 1876 to the present, providing a unique opportunity to assess TB epidemiology over 147 years in Denmark.AimOur aim was to describe the TB disease burden in Denmark in relation to historical events, living conditions and health interventions during the past 147 years.MethodsWe performed a nationwide register-based ecological study including all persons with TB in Denmark from 1876 through 2022, correlating the TB incidence to social, economic and health indicators.ResultsIn Denmark, the overall TB incidence and mortality declined markedly over the past 147 years, only marginally influenced by specific TB interventions such as sanatoria, Bacillus Calmette-Guèrin (BCG) vaccination, mass screenings and antibiotics. Parallel to this decline, the country experienced improved living conditions, as illustrated by decreased infant mortality and increased life expectancy and wealth. In 1978, Denmark became a low-incidence country for TB with risk groups predominantly affected, and with a continuous change in demographics towards fewer Danish-born cases and relatively more migrant cases.ConclusionsThe decline over time in TB incidence and mortality in Denmark preceded specific TB interventions and can, first of all, be attributed to improved living conditions. TB has now become a rare disease in Denmark, predominantly occurring in particular risk groups. Future elimination of TB will require a combination of specific health interventions in these risk groups combined with a continued focus on improving socioeconomic status and living conditions.
丹麦拥有从 1876 年至今关于结核病(TB)的卓越历史数据收集,这为评估过去 147 年丹麦的结核病流行病学提供了独特的机会。
我们旨在描述丹麦在过去 147 年中与历史事件、生活条件和卫生干预措施相关的结核病负担。
我们进行了一项全国范围内基于登记的生态研究,包括 1876 年至 2022 年期间丹麦的所有结核病患者,将结核病发病率与社会、经济和卫生指标相关联。
在过去的 147 年中,丹麦的结核病总发病率和死亡率明显下降,只有特定的结核病干预措施(如疗养院、卡介苗(BCG)接种、大规模筛查和抗生素)对其产生了轻微影响。随着发病率的下降,该国的生活条件得到了改善,婴儿死亡率下降,预期寿命和财富增加。1978 年,丹麦成为结核病低发国家,主要受高危人群影响,人口统计学特征不断变化,丹麦出生的病例逐渐减少,移民病例相对增多。
丹麦结核病发病率和死亡率的下降先于特定的结核病干预措施,可以首先归因于生活条件的改善。结核病现在在丹麦已成为一种罕见疾病,主要发生在特定的高危人群中。未来消除结核病需要在这些高危人群中结合特定的卫生干预措施,并继续关注改善社会经济地位和生活条件。